Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00399516 · ClinicalTrials.gov registry record · Phase 4

Effect of Pulse Width With Spinal Cord Stimulation

A Phase 4 study, sponsored by Boston Scientific Corporation.

Completed
Registry status
Phase 4
Development phase
21
Enrollment target

NCT00399516 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00399516, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
Phase 4
Development phase
21 participants
Enrollment target

Study Summary

The primary objective of this study is to assess the effects of varying pulse width in suprathreshold dorsal column stimulation in patients with low back pain.

Interventions

  • DEVICE Precision

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2006-11
Est. Completion 2007-11
Phase Phase 4

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT00399516

The ClinicalTrials.gov registry entry for NCT00399516 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Precision is the first listed.

NCT00399516 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00399516 about?

NCT00399516 is a clinical study titled "Effect of Pulse Width With Spinal Cord Stimulation". The primary objective of this study is to assess the effects of varying pulse width in suprathreshold dorsal column stimulation in patients with low back pain.

What is the current status of trial NCT00399516?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2006-11. Estimated completion is 2007-11.

What interventions are being tested in trial NCT00399516?

The interventions under investigation include: Precision (DEVICE).

Who is sponsoring clinical trial NCT00399516?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.